Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Novo Nordisk (stock symbol: NVO) dividend yield (TTM) as of February 04, 2026 : 3.35%Average dividend yield, last 5 years: 1.58%